Clinical trial
Randomized, Open-label Study to Evaluate the Efficacy and Safety of Doryx Tablets Compared to Doxycycline Hyclate in the Treatment of Acne Vulgaris.
NCT00635609 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Open-label Study to Evaluate the Efficacy and Safety of Doryx Tablets Compared to Doxycycline Hyclate in the Treatment of Acne Vulgaris.
- Lead sponsor
- Warner Chilcott
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2008
- Completion date
- September 30, 2008
- Enrollment
- 93 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.